These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26524354)

  • 1. [Role of pegylated-interferon in the treatment of hepatitis C in Chinese patients].
    Dou X; Wei L; Ren H; Zhang H; Zhang W; Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2015 Sep; 23(9):641-3. PubMed ID: 26524354
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel interferons for treatment of hepatitis C virus.
    Clark V; Nelson DR
    Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of interferon resistance in hepatitis C.
    Gretch D
    Lancet; 2001 Nov; 358(9294):1662-4. PubMed ID: 11728538
    [No Abstract]   [Full Text] [Related]  

  • 4. What is the role of sofosbuvir in treating hepatitis C infection?
    Carey L
    JAAPA; 2015 Feb; 28(2):16-9. PubMed ID: 25621961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hepatitis C virus genotype 4.
    Abdo AA; Lee SS
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.
    Herion D; Hoofnagle JH
    Hepatology; 1997 Mar; 25(3):769-71. PubMed ID: 9049233
    [No Abstract]   [Full Text] [Related]  

  • 7. Does iron reduction improve sustained viral responses to interferon monotherapy in hepatitis C patients? Maybe, but is this the right question?
    Shedlofsky SI
    Am J Gastroenterol; 2002 May; 97(5):1093-6. PubMed ID: 12014712
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interferon].
    Tamori A; Kawada N
    Nihon Rinsho; 2012 Apr; 70(4):620-4. PubMed ID: 22568143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial Commentary: Interferon-free Hepatitis C Treatment Efficacy From Clinical Trials Will Translate to "Real World" Outcomes.
    Martinello M; Dore GJ
    Clin Infect Dis; 2016 Apr; 62(7):927-8. PubMed ID: 26743092
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interferon-free treatment regimen for hepatitis C virus infection for extrahepatic manifestations: leukocytoclastic vasculitis].
    Ortega-García MP; Ortega-González E
    Rev Esp Quimioter; 2016 Feb; 29(1):44-6. PubMed ID: 26785225
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative Clinical Effectiveness and Value of Novel Interferon-Free Combination Therapy for Hepatitis C Genotype 1: Summary of California Technology Assessment Forum Report.
    Tice JA; Chahal HS; Ollendorf DA
    JAMA Intern Med; 2015 Sep; 175(9):1559-60. PubMed ID: 26167717
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of interferon in the treatment of viral hepatitis and its perspective].
    Zhang DF
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):2-4. PubMed ID: 21272448
    [No Abstract]   [Full Text] [Related]  

  • 14. Alternative interferons and immunomodulators in the treatment of hepatitis C.
    Alao H; Jake Liang T
    Liver Int; 2014 Feb; 34 Suppl 1():133-8. PubMed ID: 24373090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hepatitis C. Different modalities based on viral genotype].
    Pariente A
    Rev Prat; 2003 Jun; 53(11):1175-6. PubMed ID: 15185639
    [No Abstract]   [Full Text] [Related]  

  • 16. A la carte interferon for hepatitis C?
    Marcellin P; Benhamou JP; Heathcote J; Bismuth H; Desmet V; Guardia J; Lok A; Buschenfeld KH; Pagliaro L; Paumgartner G; Rodes J; Sherlock S
    Hepatology; 2000 Sep; 32(3):678-9. PubMed ID: 10991636
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b].
    Sakuma I; Enomoto N; Asahina Y; Kurosaki M; Sato C
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):930-5. PubMed ID: 7563904
    [No Abstract]   [Full Text] [Related]  

  • 18. [The combination administration of interferon in viral hepatitis].
    Zhao GD; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):5-7. PubMed ID: 21272449
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on combinations of DAAs with and without pegylated-interferon and ribavirin: triple and quadruple therapy more than doubles SVR.
    Martel-Laferrière V; Dieterich DT
    Clin Liver Dis; 2013 Feb; 17(1):93-103. PubMed ID: 23177285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction: combination antiviral therapy in chronic hepatitis C.
    Sherlock S
    J Hepatol; 1995; 23 Suppl 2():1-2. PubMed ID: 8720285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.